From Molecular Classification to Hereditary Cancer Syndrome Identification in Endometrial Cancer
Genes · 14.07.2026 · 17 (7) · 801
DOI: 10.3390/genes17070801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 14.07.2026. Verfasst von Laura Libera und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Pathology, Ospedale di Circolo, ASST Sette Laghi, 21100 Varese, Italy. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Neoplastic Syndromes, Hereditary. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Endometrial carcinoma (EC) is one of the most common gynaecological malignancies, with a steadily increasing incidence worldwide. In 2013, a novel molecular classification of ECs enabled patient stratification into four groups with important clinical management implications: (1) DNA Polymerase Epsilon (POLE)-mutated, (2) microsatellite instability-high (MSI-H/dMMR) hypermutated, (3) tumours with low somatic copy number alteration (low-SCNA), and (4) tumours with high SCNA and p53 deficiency. This molecular classification should also be used as a tool to identify hereditary cancer syndromes, as MSI-ECs can be associated with Lynch Syndrome (LS, ORPHA:144) while somatic POLE mutations may reflect polymerase proofreading-associated polyposis (PPAP syndrome, ORPHA:447877).
Methods
From 2022 to 2024, molecular classification of ECs was routinely performed on 188 consecutive cases. The results were correlated with family history and constitutional genetic testing.
Results
Somatic testing revealed that 45 ECs were dMMR and 23 carried POLE variants. Five POLE-mutated ECs also displayed concomitant MSI. For all 68 patients, cancer genetic counselling was proposed, but only 41 accepted, and of these, 26 patients were eligible for the genetic test. None of the POLE somatic variants were proven to be constitutive, whereas LS was diagnosed in seven patients with dMMR-EC; interestingly, two of these patients displayed a POLE-mutated EC.
Conclusions
Our data strongly suggest that molecular classification of ECs is important to improve the identification of LS and highlight the relevance of investigating all molecular markers at once in order to identify overlaps between POLE mutations and MMR defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Pathology, Ospedale di Circolo, ASST Sette Laghi, 21100 Varese, Italy.
- Hereditary Cancer Research Center, University of Insubria, 21100 Varese, Italy.
- SSD Specialized Laboratory of Medical Genetics, Cytogenetics and Molecular Genetics, ASST Sette Laghi, 21100 Varese, Italy.
- Unit of Pathology, Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.
ORCID-Profile: Laura Libera, Ileana Carnevali, Nora Sahnane, Maria Grazia Tibiletti
Zitieren
APA
Libera, L., Carnevali, I., Facchi, S., Sahnane, N., Travaglino, A., La Rosa, S., & Tibiletti, M. G. (2026). From Molecular Classification to Hereditary Cancer Syndrome Identification in Endometrial Cancer. Genes, 17(7), 801. https://doi.org/10.3390/genes17070801
Vancouver
Libera L, Carnevali I, Facchi S, Sahnane N, Travaglino A, La Rosa S, et al. From Molecular Classification to Hereditary Cancer Syndrome Identification in Endometrial Cancer. Genes. 2026;17(7):801. doi:10.3390/genes17070801
BibTeX
@article{Libera2026,
author = {Libera, Laura and Carnevali, Ileana and Facchi, Sofia and Sahnane, Nora and Travaglino, Antonio and La Rosa, Stefano and Tibiletti, Maria Grazia},
title = {From Molecular Classification to Hereditary Cancer Syndrome Identification in Endometrial Cancer},
journal = {Genes},
year = {2026},
volume = {17},
number = {7},
pages = {801},
doi = {10.3390/genes17070801}
}
EUVIMED